☆ 4.6 Article

A Custom DNA-Based NGS Panel for the Molecular Characterization of Patients With Diffuse Gliomas: Diagnostic and Therapeutic Applications

FRONTIERS IN ONCOLOGY (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Clinical Neurology

Cerebellar liponeurocytoma: clinical, histopathological and molecular features of a series of three cases, including one recurrent tumor

Giuseppe Broggi et al.

Summary: Cerebellar liponeurocytoma (CL) is a rare tumor characterized by neurocytic cells and a lipomatous component. Little is known about its pathogenesis and genetic landscape, but next-generation sequencing (NGS) has identified missense mutations in APC, KDR, and TP53 that may be involved in tumor progression and angiogenesis of CL.

NEUROPATHOLOGY (2022)

添加到收藏夹

Review Clinical Neurology

Glioblastoma, IDH-Wild Type With FGFR3-TACC3 Fusion: When Morphology May Reliably Predict the Molecular Profile of a Tumor. A Case Report and Literature Review

Giuseppe Broggi et al.

Summary: We report a case of recurrent GBM, IDHwt with unusual morphologic features and a molecularly-proven FGFR3-TACC3 fusion. This case expands the morphologic spectrum of FGFR3-TACC3-fused GBM, IDHwt and emphasizes the importance of promptly searching for this fusion gene in the presence of a GBM, IDHwt with unconventional morphology.

FRONTIERS IN NEUROLOGY (2022)

添加到收藏夹

Review Medicine, Research & Experimental

Grading of adult diffuse gliomas according to the 2021 WHO Classification of Tumors of the Central Nervous System

Takashi Komori

Summary: The 5th edition of WHO Classification of Tumors of the Central Nervous System incorporated new molecular markers for IDH-mutant and -wild-type astrocytoma, aiming to improve risk stratification. However, challenges and debates persist in the grading of gliomas, particularly regarding the utilization of histological and proliferative markers.

LABORATORY INVESTIGATION (2022)

添加到收藏夹

Review Clinical Neurology

Assessing the efficacy of repeat resections in recurrent glioblastoma: a systematic review

David Botros et al.

Summary: This study systematically reviewed the potential added benefit of repeat resection (RR) in recurrent GBM, finding that RR upon first recurrence may increase overall survival, and repeat resection after subsequent progressions may also be beneficial.

NEUROSURGICAL REVIEW (2021)

添加到收藏夹

Article Chemistry, Medicinal

Serum Extracellular Vesicle-Derived circHIPK3 and circSMARCA5 Are Two Novel Diagnostic Biomarkers for Glioblastoma Multiforme

Michele Stella et al.

Summary: The study suggests that sEV-derived circSMARCA5 and circHIPK3 are potential diagnostic biomarkers for GBM, especially when combined with preoperative NLR, PLR, and LMR to improve diagnostic accuracy.

PHARMACEUTICALS (2021)

添加到收藏夹

Article Clinical Neurology

FLAIRectomy in Supramarginal Resection of Glioblastoma Correlates With Clinical Outcome and Survival Analysis: A Prospective, Single Institution, Case Series

Francesco Certo et al.

Summary: The study demonstrated that EOTR based on FLAIR and 5-ALA fluorescence is feasible and provides better survival predictions. FLAIR volumetric evaluation showed larger tumor volume and stronger correlation with survival outcomes compared to T1-weighted MR images.

OPERATIVE NEUROSURGERY (2021)

添加到收藏夹

Article Clinical Neurology

The efficacy of immunohistochemistry in the diagnosis of molecular genetic alterations in central nervous system gliomas: Next-generation sequencing of 212 mutations in 112 patients

Elena V. Daoud et al.

CLINICAL NEUROPATHOLOGY (2021)

添加到收藏夹

Article Oncology

EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood

Michael Weller et al.

Summary: The European Association of Neuro-Oncology (EANO) has released guidelines for the diagnosis, treatment, and follow-up of adult patients with diffuse gliomas, incorporating major changes in diagnostic algorithms based on the 2016 update of the WHO Classification of Tumors of the Central Nervous System, as well as evidence from recent large clinical trials.

NATURE REVIEWS CLINICAL ONCOLOGY (2021)

添加到收藏夹

Review Medical Laboratory Technology

Application of Next Generation Sequencing in Laboratory Medicine

Yiming Zhong et al.

Summary: This review discusses the rapid advancement of next-generation sequencing technology and its wide clinical applications in precision medicine, particularly in inherited diseases, oncology, and infectious diseases. It highlights the importance of NGS in clinical oncology, FDA-approved NGS panels, and the role of host microbiome in infectious diseases. The review also addresses the challenges and future prospects of clinical NGS tests.

ANNALS OF LABORATORY MEDICINE (2021)

添加到收藏夹

Review Biochemistry & Molecular Biology

Receptor Tyrosine Kinase Signaling and Targeting in Glioblastoma Multiforme

Manali Tilak et al.

Summary: Glioblastoma multiforme (GBM) is a deadly cancer with limited response to existing therapies. Subtypes of GBM with distinct genetic signatures show aberrant activation of signal transduction pathways. Current research focuses on understanding these molecular alterations to develop more efficient targeted therapies.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

添加到收藏夹

Article Neurosciences

The number of methylated CpG sites within the MGMT promoter region linearly correlates with outcome in glioblastoma receiving alkylating agents

Sebastian Siller et al.

Summary: MGMT-promoter methylation is associated with favorable outcome in glioblastoma patients. The total number of methylated CpG-sites within the MGMT-promoter correlates linearly with survival, especially in patients who received adjuvant temozolomide therapy. This analysis adds predictive value to conventional methods of determining MGMT-promoter status.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2021)

添加到收藏夹

Review Oncology

Prognostic and Therapeutic Roles of the Insulin Growth Factor System in Glioblastoma

Elena Tirro et al.

Summary: The IGF signaling pathway plays a key role in the pathogenesis of GBM, contributing to clinical significance and resistance development to standard and experimental treatments.

FRONTIERS IN ONCOLOGY (2021)

添加到收藏夹

Article Clinical Neurology

Non-IDH1-R132H IDH1/2 mutations are associated with increased DNA methylation and improved survival in astrocytomas, compared to IDH1-R132H mutations

C. Mircea S. Tesileanu et al.

Summary: Somatic mutations in the isocitrate dehydrogenase genes IDH1 and IDH2 are common in various tumor types, with gliomas showing a particularly high frequency of the IDH1(R132H) mutation. Patients with IDH1(R132H) mutations tend to have lower DNA methylation levels and higher gene expression compared to other IDH1/2 mutations. The different prognosis between IDH1(R132H) mutated astrocytomas and non-R132H IDH1/2-mutated astrocytomas highlights the clinical relevance of distinct IDH mutations.

ACTA NEUROPATHOLOGICA (2021)

添加到收藏夹

Review Oncology

A Systematic Review of Glioblastoma-Targeted Therapies in Phases II, III, IV Clinical Trials

Elisabete Cruz Da Silva et al.

Summary: This review provides a detailed analysis of targeted therapies for glioblastoma over the last 20 years, covering 257 clinical trials on adults with newly diagnosed or recurrent GBMs in Phases II-IV. Despite current treatment protocols, the survival of patients remains under 18 months, with ongoing clinical studies to explore new therapeutic options. The most frequently studied targets include EGFR, tyrosine kinase receptors, and VEGF/VEGFR, with various other targets and drugs also of interest for potential future therapies.

CANCERS (2021)

添加到收藏夹

Article Oncology

Diagnostic Utility of the Immunohistochemical Expression of Serine and Arginine Rich Splicing Factor 1 (SRSF1) in the Differential Diagnosis of Adult Gliomas

Giuseppe Broggi et al.

Summary: The study investigated the immunohistochemical expression of SRSF1 in various adult gliomas, suggesting it as a promising diagnostic marker for astrocytomas and oligodendrogliomas. The increased expression of SRSF1 may help in excluding entities like ependymomas and pilocytic astrocytomas in the differential diagnosis of brain tumors.

CANCERS (2021)

添加到收藏夹

Review Oncology

The 2021 WHO Classification of Tumors of the Central Nervous System: a summary

David N. Louis et al.

Summary: The fifth edition of the WHO Classification of Tumors of the Central Nervous System integrates molecular diagnostics into CNS tumor classification, introduces different approaches to tumor nomenclature and grading, and emphasizes the importance of integrated diagnoses and layered reports.

NEURO-ONCOLOGY (2021)

添加到收藏夹

Article Endocrinology & Metabolism

SRSF-1 and microvessel density immunohistochemical analysis by semi-automated tissue microarray in prostate cancer patients with diabetes (DIAMOND study)

Giuseppe Broggi et al.

Summary: The study revealed the association between SRSF-1 and MVD expression in prostate cancer patients with a worse prognosis, particularly linked to increased cell proliferation. Further data supported these findings, which may help uncover genetic alterations associated with higher SRSF-1 expression and worse outcomes.

PROSTATE (2021)

添加到收藏夹

Review Oncology

Glioblastoma: Emerging Treatments and Novel Trial Designs

Vincenzo Di Nunno et al.

Summary: Glioblastoma patients face a lack of systemic agents with clinical efficacy, emphasizing the need for novel therapeutic approaches. However, the increasing availability of novel compounds and better biological knowledge of the disease offer hope for more promising clinical trials. Focus on novel trial designs and emerging treatment strategies is essential for moving forward in the management of glioblastoma.

CANCERS (2021)

添加到收藏夹

Article Clinical Neurology

cIMPACT-NOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas

Daniel J. Brat et al.

ACTA NEUROPATHOLOGICA (2020)

添加到收藏夹

Article Clinical Neurology

cIMPACT-NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT-Utrecht meeting on future CNS tumor classification and grading

David N. Louis et al.

BRAIN PATHOLOGY (2020)

添加到收藏夹

Article Oncology

MGMT promoter methylation level in newly diagnosed low-grade glioma is a predictor of hypermutation at recurrence

Radhika Mathur et al.

NEURO-ONCOLOGY (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Gene expression profiling of glioblastoma cell lines depending on TP53 status after tumor-treating fields (TTFields) treatment

Yeon-Joo Lee et al.

SCIENTIFIC REPORTS (2020)

添加到收藏夹

Article Neurosciences

Homozygous deletion ofCDKN2Aby fluorescence in situ hybridization is prognostic in grade 4, but not grade 2 or 3, IDH-mutant astrocytomas

Daniel F. Marker et al.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2020)

添加到收藏夹

Review Oncology

Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group

F. Mosele et al.

ANNALS OF ONCOLOGY (2020)

添加到收藏夹

Article Oncology

Targeted next-generation sequencing panel (TruSight Tumor 170) in diffuse glioma: a single institutional experience of 135 cases

Kiyong Na et al.

JOURNAL OF NEURO-ONCOLOGY (2019)

添加到收藏夹

Article Oncology

Chk1 Inhibition Restores Inotuzumab Ozogamicin Citotoxicity in CD22-Positive Cells Expressing Mutant p53

Elena Tirro et al.

FRONTIERS IN ONCOLOGY (2019)

添加到收藏夹

Article Oncology

Efficacy of Nilotinib in a CML Patient Expressing the Three-way Complex Variant Translocation t(2;9;22)

Elena Tirro et al.

ANTICANCER RESEARCH (2019)

添加到收藏夹

Article Oncology

Design and Validation of a Gene-Targeted, Next-Generation Sequencing Panel for Routine Diagnosis in Gliomas

Nicky D'Haene et al.

CANCERS (2019)

添加到收藏夹

Article Oncology

CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012-2016

Quinn T. Ostrom et al.

NEURO-ONCOLOGY (2019)

添加到收藏夹

Review Oncology

Next generation sequencing-based gene panel tests for the management of solid tumors

Masayuki Nagahashi et al.

CANCER SCIENCE (2019)

添加到收藏夹

Article Oncology

Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods

J. Ferlay et al.

INTERNATIONAL JOURNAL OF CANCER (2019)

添加到收藏夹

Article Oncology

Clinically Actionable Insights into Initial and Matched Recurrent Glioblastomas to Inform Novel Treatment Approaches

H. P. Ellis et al.

JOURNAL OF ONCOLOGY (2019)

添加到收藏夹

Review Oncology

Gene Fusion in Malignant Glioma: An Emerging Target for Next-Generation Personalized Treatment

Tao Xu et al.

TRANSLATIONAL ONCOLOGY (2018)

添加到收藏夹

Article Clinical Neurology

Molecular Diagnostics of Gliomas Using Next Generation Sequencing of a Glioma-Tailored Gene Panel

Angela Zacher et al.

BRAIN PATHOLOGY (2017)

添加到收藏夹

Article Pathology

Targeted Next-Generation Sequencing in Molecular Subtyping of Lower-Grade Diffuse Gliomas Application of the World Health Organization's 2016 Revised Criteria for Central Nervous System Tumors

Jamal H. Carter et al.

JOURNAL OF MOLECULAR DIAGNOSTICS (2017)

添加到收藏夹

Review Genetics & Heredity

Reference standards for next-generation sequencing

Simon A. Hardwick et al.

NATURE REVIEWS GENETICS (2017)

添加到收藏夹

Article Multidisciplinary Sciences

PDGF Family Expression in Glioblastoma Multiforme: Data Compilation from Ivy Glioblastoma Atlas Project Database

Isabella Gomes Cantanhede et al.

SCIENTIFIC REPORTS (2017)

添加到收藏夹

Letter Clinical Neurology

Molecular and clinical heterogeneity of adult diffuse low-grade IDH wild-type gliomas: assessment of TERT promoter mutation and chromosome 7 and 10 copy number status allows superior prognostic stratification

Maarten M. J. Wijnenga et al.

ACTA NEUROPATHOLOGICA (2017)

添加到收藏夹

Article Oncology

Molecular classification of anaplastic oligodendroglioma using next-generation sequencing: a report of the prospective randomized EORTC Brain Tumor Group 26951 phase III trial

Hendrikus J. Dubbink et al.

NEURO-ONCOLOGY (2016)

添加到收藏夹

Article Oncology

Targeted next-generation sequencing panel (GlioSeq) provides comprehensive genetic profiling of central nervous system tumors

Marina N. Nikiforova et al.

NEURO-ONCOLOGY (2016)

添加到收藏夹

Review Clinical Neurology

The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary

David N. Louis et al.

ACTA NEUROPATHOLOGICA (2016)

添加到收藏夹

Article Cell Biology

Utility of ATRX immunohistochemistry in diagnosis of adult diffuse gliomas

Masako Ikemura et al.

HISTOPATHOLOGY (2016)

添加到收藏夹

Article Pathology

Diagnostic Detection of Allelic Losses and Imbalances by Next-Generation Sequencing 1p/19q Co-Deletion Analysis of Gliomas

Hendrikus J. Dubbink et al.

JOURNAL OF MOLECULAR DIAGNOSTICS (2016)

添加到收藏夹

Article Biotechnology & Applied Microbiology

PTEN gene mutations correlate to poor prognosis in glioma patients: a meta-analysis

Feng Han et al.

ONCOTARGETS AND THERAPY (2016)

添加到收藏夹

Article Oncology

Prevalence of actionable mutations and copy number alterations and the price of a genomic testing panel

Chan Shen et al.

ONCOTARGET (2016)

添加到收藏夹

Review Biochemistry & Molecular Biology

Temozolomide resistance in glioblastoma multiforme

Sang Y. Lee

GENES & DISEASES (2016)

添加到收藏夹

Article Clinical Neurology

Revisiting TP53 Mutations and Immunohistochemistry-A Comparative Study in 157 Diffuse Gliomas

Hirokazu Takami et al.

BRAIN PATHOLOGY (2015)

添加到收藏夹

Article Biochemistry & Molecular Biology

COSMIC: exploring the world's knowledge of somatic mutations in human cancer

Simon A. Forbes et al.

NUCLEIC ACIDS RESEARCH (2015)

添加到收藏夹

Article Oncology

The genetic landscape of anaplastic astrocytoma

Patrick J. Killela et al.

ONCOTARGET (2014)

添加到收藏夹

Review Oncology

Glioblastoma Multiforme: A Look Inside Its Heterogeneous Nature

Maria-del-Mar Inda et al.

CANCERS (2014)

添加到收藏夹

Article Biochemistry & Molecular Biology

The Somatic Genomic Landscape of Glioblastoma

Cameron W. Brennan et al.

CELL (2013)

添加到收藏夹

Review Oncology

Detection of structural DNA variation from next generation sequencing data: a review of informatic approaches

Haley J. Abel et al.

CANCER GENETICS (2013)

添加到收藏夹

Article Genetics & Heredity

Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas

Gang Wu et al.

NATURE GENETICS (2012)

添加到收藏夹

Article Oncology

Molecular analysis of anaplastic oligodendroglial tumors in a prospective randomized study: A report from EORTC study 26951

Mathilde C. M. Kouwenhoven et al.

NEURO-ONCOLOGY (2009)

添加到收藏夹

Review Radiology, Nuclear Medicine & Medical Imaging

From the archives of the AFIP - Oligodendroglioma and its variants: Radiologic-pathologic correlation

KK Koeller et al.

RADIOGRAPHICS (2005)

添加到收藏夹

Article Medicine, General & Internal

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

R Stupp et al.

NEW ENGLAND JOURNAL OF MEDICINE (2005)

添加到收藏夹

Article Clinical Neurology

Clinical utility of fluorescence in situ hybridization (FISH) in morphologically ambiguous gliomas with hybrid oligodendroglial/astrocytic features

CE Fuller et al.

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2003)

添加到收藏夹

Review Biotechnology & Applied Microbiology

A review of fluorescence in situ hybridization (FISH): Current status and future prospects

J Nath et al.

BIOTECHNIC & HISTOCHEMISTRY (2000)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.